Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,426.20
-3.80 (-0.27%)
Jul 10, 2026, 3:29 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 198.32 billion as of July 10, 2026. Its market cap has decreased by -16.11% in one year.
Market Cap
198.32B
Enterprise Value
221.16B
Revenue
31.15B
Ranking
n/a
PE Ratio
31.62
Stock Price
1,426.20
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 198.32B, an increase of 139.79%. That is a compound annual growth rate of 10.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 198.32B | -3.30% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 413.08B |
| Gland Pharma | 406.87B |
| Emcure Pharmaceuticals | 343.06B |
| Wockhardt | 297.57B |
| Piramal Pharma | 228.26B |
| NATCO Pharma | 172.23B |
| Cohance Lifesciences | 168.39B |
| Alembic Pharmaceuticals | 160.57B |